Indian cough syrup maker Maiden Pharmaceuticals is making an attempt to establish particulars from its purchaser in The Gambia associated to the deaths of kids, which the World Health Organization mentioned might be linked to its merchandise, one in all its administrators mentioned on Thursday.
“We are trying to ascertain the situation as it only emerged this morning,” Naresh Kumar Goel instructed Reuters. “We are attempting to establish with the client what precisely occurred. We are usually not promoting something in India.”
WHO Director-General Tedros Adhanom Ghebreyesus instructed reporters on Wednesday that the UN company is investigating 66 deaths from severe kidney accidents with India’s drug regulator.
With inputs from TheIndianEXPRESS
